Kaptive web: User-Friendly capsule and lipopolysaccharide serotype prediction for Klebsiella genomes

Journal of Clinical Microbiology

Volumn 56, Issue 6, 2018, Pages

  Wick, Ryan R ^a   Heinz, Eva ^b   Holt, Kathryn E ^a   Wyres, Kelly L ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

Capsular polysaccharide; Capsule; Genome analysis; Genomics; Klebsiella; Lipopolysaccharide; Molecular epidemiology

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CARBAPENEMASE; BACTERIAL PROTEIN; BETA LACTAMASE; LIPOPOLYSACCHARIDE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL CAPSULE; BACTERIAL GENOME; CLONAL SPECIES; GENE LOCUS; INTERNET; KLEBSIELLA PNEUMONIAE; MICROBIAL DIVERSITY; MULTIDRUG RESISTANCE; NONHUMAN; ONLINE SYSTEM; PREDICTION; PRIORITY JOURNAL; SEROTYPE; WEB BROWSER; GENETICS; GENOMICS; KLEBSIELLA; KLEBSIELLA INFECTION; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; SOFTWARE;

BACTERIAL CAPSULES; BACTERIAL PROTEINS; BETA-LACTAMASES; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOME, BACTERIAL; GENOMICS; INTERNET; KLEBSIELLA; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; LIPOPOLYSACCHARIDES; MOLECULAR EPIDEMIOLOGY; PHYLOGENY; SEROGROUP; SOFTWARE;

EID: 85047924055     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00197-18     Document Type: Article

References (65)

1. U.S. Food and Drug Administration. 2017. GenomeTrakr program. U.S. Food and Drug Administration, Silver Spring, MD. https://www.accessdata.fda.gov/scripts/fdatrack/view/track_project.cfm?program cfsan&idCFSAN-ORS-Genometrakr.
2. Jackson BR, Tarr C, Strain E, Jackson KA, Conrad A, Carleton H, Katz LS, Stroika S, Gould LH, Mody RK, Silk BJ, Beal J, Chen Y, Timme R, Doyle M, Fields A, Wise M, Tillman G, Defibaugh-Chavez S, Kucerova Z, Sabol A, Roache K, Trees E, Simmons M, Wasilenko J, Kubota K, Pouseele H, Klimke W, Besser J, Brown E, Allard M, Gerner-Smidt P. 2016. Implementation of nationwide real-time whole-genome sequencing to enhance listeriosis outbreak detection and investigation. Clin Infect Dis 63: 380–386. https://doi.org/10.1093/cid/ciw242.
3. Kwong JC, Mercoulia K, Tomita T, Easton M, Li HY, Bulach DM, Stinear TP, Seemann T, Howden BP. 2016. Prospective whole-genome sequencing enhances national surveillance of Listeria monocytogenes. J Clin Microbiol 54:333–342. https://doi.org/10.1128/JCM.02344-15.
4. Török M, Peacock S. 2016. Microbial whole-genome sequencing: applications in clinical microbiology and public health, p 32– 48. In Persing D, Tenover F, Hayden R, Ieven M, Miller M, Nolte F, Tang Y, van Belkum A (ed), Molecular microbiology: diagnostic principles and practice, 3rd ed. ASM Press, Washington, DC.
5. Witney AA, Cosgrove CA, Arnold A, Hinds J, Stoker NG, Butcher PD. 2016. Clinical use of whole genome sequencing for Mycobacterium tuberculosis. BMC Med 14:46. https://doi.org/10.1186/s12916-016-0598-2.
6. Robilotti E, Kamboj M. 2015. Integration of whole-genome sequencing into infection control practices: the potential and the hurdles. J Clin Microbiol 53:1054–1055. https://doi.org/10.1128/JCM.00349-15.
7. Kwong JC, McCallum N, Sintchenko V, Howden BP. 2015. Whole genome sequencing in clinical and public health microbiology. Pathology 47: 199–210. https://doi.org/10.1097/PAT.0000000000000235.
8. Wyres KL, Conway TC, Garg S, Queiroz C, Reumann M, Holt K, Rusu LI. 2014. WGS analysis and interpretation in clinical and public health microbiology laboratories: what are the requirements and how do existing tools compare? Pathogens 3:437–458. https://doi.org/10.3390/pathogens3020437.
9. Zankari E, Hasman H, Cosentino S, Vestergaard M, Rasmussen S, Lund O, Aarestrup FM, Larsen MV. 2012. Identification of acquired antimicrobial resistance genes. J Antimicrob Chemother 67:2640–2644. https://doi.org/10.1093/jac/dks261.
10. Joensen KG, Tetzschner AMM, Iguchi A, Aarestrup FM, Scheutz F. 2015. Rapid and easy in silico serotyping of Escherichia coli isolates by use of whole-genome sequencing data. J Clin Microbiol 53:2410–2426. https://doi.org/10.1128/JCM.00008-15.
11. Kapatai G, Sheppard CL, Al-Shahib A, Litt DJ, Underwood AP, Harrison TG, Fry NK. 2016. Whole genome sequencing of Streptococcus pneumoniae: development, evaluation and verification of targets for serogroup and serotype prediction using an automated pipeline. PeerJ 4:e2477. https://doi.org/10.7717/peerj.2477.
12. Ingle DJ, Valcanis M, Kuzevski A, Tauschek M, Inouye M, Stinear T, Levine MM, Robins-Browne RM, Holt KE. 2016. In silico serotyping of E. coli from short read data identifies limited novel O-loci but extensive diversity of O:H serotype combinations within and between pathogenic lineages. Microb Genom 2:e000064. https://doi.org/10.1099/mgen.0.000064.
13. Pendleton JN, Gorman SP, Gilmore BF. 2013. Clinical relevance of the ESKAPE pathogens. Exp Rev Anti Infect Ther 11:297–308. https://doi.org/10.1586/eri.13.12.
14. Centers for Disease Control and Prevention. 2013. Antibiotic resistance threats in the United States, 2013. Centers for Disease Control and Prevention, Atlanta, GA.
15. World Health Organization. 2014. Antimicrobial resistance: global report on surveillance. World Health Organization, Geneva, Switzerland.
16. Pan YJ, Lin TL, Lin YT, Su PA, Chen CT, Hsieh PF, Hsu CR, Chen CC, Hsieh YC, Wang JT. 2015. Identification of capsular types in carbapenem-resistant Klebsiella pneumoniae strains by wzc sequencing and implications for capsule depolymerase treatment. Antimicrob Agents Chemother 59:1038–1047. https://doi.org/10.1128/AAC.03560-14.
17. Aleshkin AV, Ershova ON, Volozhantsev NV, Svetoch EA, Popova AV, Rubalskii EO, Borzilov AI, Aleshkin VA, Afanas’ev SS, Karaulov AV, Ga-limzyanov KM, Rubalsky OV, Bochkareva SS. 2016. Phagebiotics in treatment and prophylaxis of healthcare-associated infections. Bacteriophage 6:e1251379. https://doi.org/10.1080/21597081.2016.1251379.
18. D’Andrea MM, Marmo P, Henrici De Angelis L, Palmieri M, Ciacci N, Di Lallo G, Demattè E, Vannuccini E, Lupetti P, Rossolini GM, Thaller MC. 2017. BO1E, a newly discovered lytic bacteriophage targeting carbapenemase-producing Klebsiella pneumoniae of the pandemic clonal group 258 clade II lineage. Sci Rep 7:2614. https://doi.org/10.1038/s41598-017-02788-9.
19. Pallavali RR, Degati VL, Lomada D, Reddy MC, Durbaka VRP. 2017. Isolation and in vitro evaluation of bacteriophages against MDR-bacterial isolates from septic wound infections. PLoS One 12:e0179245. https://doi.org/10.1371/journal.pone.0179245.
20. Guachalla LM, Stojkovic K, Hartl K, Kaszowska M, Kumar Y, Wahl B, Paprotka T, Nagy E, Lukasiewicz J, Nagy G, Szijártó V. 2017. Discovery of monoclonal antibodies cross-reactive to novel subserotypes of K. pneumoniae O3. Sci Rep 7:6635. https://doi.org/10.1038/s41598-017-06682-2.
21. Szijártó V, Guachalla LM, Hartl K, Varga C, Banerjee P, Stojkovic K, Kaszowska M, Nagy E, Lukasiewicz J, Nagy G. 2016. Both clades of the epidemic KPC-producing Klebsiella pneumoniae clone ST258 share a modified galactan O-antigen type. Int J Med Microbiol 306:89–98. https://doi.org/10.1016/j.ijmm.2015.12.002.
22. Motley MP, Fries BC. 2017. A new take on an old remedy: generating antibodies against bacteria in a postantibiotic world. mSphere 2:e00397-17. https://doi.org/10.1128/mSphere.00397-17.
23. Pennini ME, De Marco A, Pelletier M, Bonnell J, Cvitkovic R, Beltramello M, Cameroni E, Bianchi S, Zatta F, Zhao W, Xiao X, Camara MM, DiGian-domenico A, Semenova E, Lanzavecchia A, Warrener P, Suzich J, Wang Q, Corti D, Stover CK. 2017. Immune stealth-driven O2 serotype prevalence and potential for therapeutic antibodies against multidrug resistant Klebsiella pneumoniae. Nat Commun 8:1991. https://doi.org/10.1038/s41467-017-02223-7.
24. Ahmad TA, El-Sayed LH, Haroun M, Hussein AA, El Ashry el SH. 2012. Development of immunization trials against Klebsiella pneumoniae. Vaccine 30:2411–2420. https://doi.org/10.1016/j.vaccine.2011.11.027.
25. Follador R, Heinz E, Wyres KL, Ellington MJ, Kowarik M, Holt KE, Thomson NR. 2016. The diversity of Klebsiella pneumoniae surface polysaccharides. Microb Genom 2:e000073. https://doi.org/10.1099/mgen.0.000073.
26. Seeberger PH, Pereira CL, Khan N, Xiao G, Diago-Navarro E, Reppe K, Opitz B, Fries BC, Witzenrath M. 2017. A semi-synthetic glycoconjugate vaccine candidate for carbapenem-resistant Klebsiella pneumoniae. An-gew Chem Int Ed Engl 56:13973–13978. https://doi.org/10.1002/anie.201700964.
27. Merino S, Camprubí S, Albertí S, Benedí VJ, Tomas JM. 1992. Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing. Infect Immun 60:2529 –2535.
28. Evrard B, Balestrino D, Dosgilbert A, Bouya-Gachancard JL, Charbonnel N, Forestier C, Tridon A. 2010. Roles of capsule and lipopolysaccharide O antigen in interactions of human monocyte-derived dendritic cells and Klebsiella pneumoniae. Infect Immun 78:210–219. https://doi.org/10.1128/IAI.00864-09.
29. March C, Cano V, Moranta D, Llobet E, Pérez-Gutiérrez C, Tomás JM, Suárez T, Garmendia J, Bengoechea JA. 2013. Role of bacterial surface structures on the interaction of Klebsiella pneumoniae with phagocytes. PLoS One 8:e56847. https://doi.org/10.1371/journal.pone.0056847.
30. Hsieh P, Lin T, Yang F, Wu M, Pan Y, Wu S, Wang J. 2012. Lipopolysaccharide O1 antigen contributes to the virulence in Klebsiella pneumoniae causing pyogenic liver abscess. PLoS One 7:e33155. https://doi.org/10.1371/journal.pone.0033155.
31. Cortés G, Borrell N, Astorza D, Gómez C, Sauleda J, Albertí S. 2002. Molecular analysis of the contribution of the capsular polysaccharide and the lipopolysaccharide O side chain to the virulence of Klebsiella pneumoniae in a murine model of pneumonia. Infect Immun 70: 2583–2590. https://doi.org/10.1128/IAI.70.5.2583-2590.2002.
32. Brisse S, Fevre C, Passet V, Issenhuth-Jeanjean S, Tournebize R, Diancourt L, Grimont P. 2009. Virulent clones of Klebsiella pneumoniae: identification and evolutionary scenario based on genomic and phenotypic characterization. PLoS One 4:e4982. https://doi.org/10.1371/journal.pone.0004982.
33. Luo Y, Wang Y, Ye L, Yang J. 2014. Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China. Clin Microbiol Infect 20:O818 –O824. https://doi.org/10.1111/1469-0691.12664.
34. Lee IR, Molton JS, Wyres KL, Gorrie C, Wong J, Hoh CH, Teo J, Kalimuddin S, Lye DC, Archuleta S, Holt KE, Gan Y-H. 2016. Differential host susceptibility and bacterial virulence factors driving Klebsiella liver abscess in an ethnically diverse population. Sci Rep 6:29316. https://doi.org/10.1038/srep29316.
35. Turton JF, Perry C, Elgohari S, Hampton CV. 2010. PCR characterization and typing of Klebsiella pneumoniae using capsular type-specific, variable number tandem repeat and virulence gene targets. J Med Microbiol 59:541–547. https://doi.org/10.1099/jmm.0.015198-0.
36. Fang C, Shih Y, Cheong C, Yi W. 2015. Rapid and accurate determination of lipopolysaccharide O-antigen types in Klebsiella pneumoniae with a novel PCR-based O-genotyping method. J Clin Microbiol 54:666–675. https://doi.org/10.1128/JCM.02494-15.
37. Brisse S, Passet V, Haugaard AB, Babosan A, Kassis-Chikhani N, Struve C, Decré D. 2013. wzi gene sequencing, a rapid method for determination of capsular type for Klebsiella strains. J Clin Microbiol 51:4073– 4078. https://doi.org/10.1128/JCM.01924-13.
38. Wyres KL, Wick RR, Gorrie C, Jenney A, Follador R, Thomson NR, Holt KE. 2016. Identification of Klebsiella capsule synthesis loci from whole genome data. Microb Genom 2:e000102. https://doi.org/10.1099/mgen.0.000102.
39. Whitfield C, Trent MS. 2014. Biosynthesis and export of bacterial lipopolysaccharides. Annu Rev Biochem 83:99–128. https://doi.org/10.1146/annurev-biochem-060713-035600.
40. Whitfield C, Richards JC, Perry MB, Clarke BR, Maclean LL. 1991. Expression of two structurally distinct D-galactan O antigens in the lipopolysaccharide of Klebsiella pneumoniae serotype O1. J Bacteriol 173: 1420–1431. https://doi.org/10.1128/jb.173.4.1420-1431.1991.
41. Clarke BR, Whitfield C. 1992. Molecular cloning of the rfb region of Klebsiella pneumoniae serotype O1:K20: the rfb gene cluster is responsible for synthesis of the D-galactan I O polysaccharide. J Bacteriol 174:4614–4621. https://doi.org/10.1128/jb.174.14.4614-4621.1992.
42. Sugiyama T, Kido N, Kato Y, Koide N, Yoshida T, Yokochi T. 1997. Evolutionary relationship among rfb gene clusters synthesizing mannose homopo-lymer as O-specific polysaccharides in Escherichia coli and Klebsiella pneumoniae. Gene 198:111–113. https://doi.org/10.1016/S0378-1119(97)00300-4.
43. Trautmann M, Ruhnke M, Rukavina T, Held TK, Cross AS, Marre R, Whitfield C. 1997. O-antigen seroepidemiology of Klebsiella clinical isolates and implications for immunoprophylaxis of Klebsiella infections. Clin Diagn Lab Immun 4:550–555.
44. Hsieh PF, Wu MC, Yang FL, Chen CT, Lou TC, Chen YY, Wu SH, Sheu JC, Wang JT. 2014. D-Galactan II is an immunodominant antigen in O1 lipopolysaccharide and affects virulence in Klebsiella pneumoniae: implication in vaccine design. Front Microbiol 5:608. https://doi.org/10.3389/fmicb.2014.00608.
45. Kelly RF, Perry MB, MacLean LL, Whitfield C. 1995. Structures of the O-antigens of Klebsiella serotypes 02 (2a,2e), 02 (2a,2e,2h), and 02 (2a,2f,2g), members of a family of related D-galactan O-antigens in Klebsiella spp. Innate Immun 2:131–140. https://doi.org/10.1177/096805199500200208.
46. Rahn A, Drummelsmith J, Whitfield C. 1999. Conserved organization in the cps gene clusters for expression of Escherichia coli group 1 K antigens: relationship to the colanic acid biosynthesis locus and the cps genes from Klebsiella pneumoniae. J Bacteriol 181:2307–2713.
47. Arakawa Y, Wacharotayankun R, Nagatsuka T, Ito H, Kato N, Ohta M. 1995. Genomic organization of the Klebsiella pneumoniae cps region responsible for serotype K2 capsular polysaccharide synthesis in the virulent strain Chedid. J Bacteriol 177:1788–1796. https://doi.org/10.1128/jb.177.7.1788-1796.1995.
48. Pan Y-J, Lin T-L, Chen C-T, Chen Y-Y, Hsieh P-F, Hsu C-R, Wu M-C, Wang J-T. 2015. Genetic analysis of capsular polysaccharide synthesis gene clusters in 79 capsular types of Klebsiella spp. Sci Rep 5:15573. https://doi.org/10.1038/srep15573.
49. Ørskov IDA, Fife-Asbury MA. 1977. New Klebsiella capsular antigen, K82, and the deletion of five of those previously assigned. Int J Syst Evol Microbiol 27:386–387. https://doi.org/10.1099/00207713-27-4-386.
50. Long SW, Olsen RJ, Eagar TN, Beres SB, Zhao P, Davis J, Brettin T, Xia F, Musser J. 2017. Population genomic analysis of 1,777 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates, Houston, Texas: unexpected abundance of clonal group 307. mBio 8:e00489-17. https://doi.org/10.1128/mBio.00489-17.
51. Gorrie CL, Mirceta M, Wick RR, Judd LM, Wyres KL, Thomson NR, Strugnell RA, Pratt NF, Garlick JF, Watson KM, Hunter PC, McGloughlin SA, Spelman DW, Jenney AWJ, Holt KE. 11 January 2018. Antimicrobial resistant Klebsiella pneumoniae carriage and infection in specialized geriatric care wards linked to acquisition in the referring hospital. Clin Infect Dis https://doi.org/10.1093/cid/ciy027.
52. Anes J, Hurley D, Martins M, Fanning S. 2017. Exploring the genome and phenotype of multi-drug resistant Klebsiella pneumoniae of clinical origin. Front Microbiol 8:1913. https://doi.org/10.3389/fmicb.2017.01913.
53. Di Pierro M. 2011. web2py for scientific applications. Comput Sci Eng 13:64–69. https://doi.org/10.1109/MCSE.2010.97.
54. Holt KE, Wertheim H, Zadoks RN, Baker S, Whitehouse CA, Dance D, Jenney A, Connor TR, Hsu LY, Severin J, Brisse S, Cao H, Wilksch J, Gorrie C, Schultz MB, Edwards DJ, Nguyen Van K, Nguyen TV, Dao TT, Mensink M, Minh Le V, Nhu NTK, Schultsz C, Kuntaman K, Newton PN, Moore CE, Strugnell RA, Thomson NR. 2015. Genomic analysis of diversity, population structure, virulence, and antimicrobial resistance in Klebsiella pneumoniae, an urgent threat to public health. Proc Natl Acad Sci U S A 112:E3574–E3581. https://doi.org/10.1073/pnas.1501049112.
55. Wick RR, Judd LM, Gorrie CL, Holt KE. 2017. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13:e1005595. https://doi.org/10.1371/journal.pcbi.1005595.
56. Wick RR, Judd LM, Gorrie CL, Holt KE. 2017. Completing bacterial genome assemblies with multiplex MinION sequencing. Microb Genom 3:e000132. https://doi.org/10.1099/mgen.0.000132.
57. Pan YJ, Lin TL, Chen YH, Hsu CR, Hsieh PF, Wu MC, Wang JT. 2013. Capsular types of Klebsiella pneumoniae revisited by wzc sequencing. PLoS One 8:e80670. https://doi.org/10.1371/journal.pone.0080670.
58. Satlin MJ, Chen L, Patel G, Gomez-simmonds A, Weston G, Kim AC, Seo SK, Rosenthal ME, Sperber SJ, Jenkins SG, Hamula CL, Uhlemann A, Levi MH, Fries BC, Tang Y, Juretschko S, Rojtman D, Hong T, Mathema B, Jacobs M, Walsh T, Bonomo R, Kreiswirth B. 2017. Multicenter clinical and molecular epidemiological analysis of bacteremia epicenter of the United States. Antimicrob Agents Chemother 61:e02349-16. https://doi .org/10.1128/AAC.02349-16.
59. Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, Brolund A, Giske CG. 2009. Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother 53: 3365–3370. https://doi.org/10.1128/AAC.00126-09.
60. Deleo FR, Chen L, Porcella SF, Martens CA, Kobayashi SD, Porter AR, Chavda KD, Jacobs MR, Mathema B, Olsen RJ, Bonomo RA, Musser JM, Kreiswirth BN. 2014. Molecular dissection of the evolution of carbapenem-resistant multilocus sequence type 258 Klebsiella pneumoniae. Proc Natl Acad Sci U S A 111:4988–4993. https://doi.org/10.1073/pnas.1321364111.
61. Wyres KL, Gorrie C, Edwards DJ, Wertheim HFL, Hsu LY, Van Kinh N, Zadoks R, Baker S, Holt KE. 2015. Extensive capsule locus variation and large-scale genomic recombination within the Klebsiella pneumoniae clonal group 258. Genome Biol Evol 7:1267–1279. https://doi.org/10 .1093/gbe/evv062.
62. Wyres KL, Holt KE. 2016. Klebsiella pneumoniae population genomics and antimicrobial-resistant clones. Trends Microbiol 24:944 –956. https://doi.org/10.1016/j.tim.2016.09.007.
63. Zhou K, Lokate M, Deurenberg RH, Tepper M, Arends JP, Raangs EGC, Lo-Ten-Foe J, Grundmann H, Rossen JWA, Friedrich AW. 2016. Use of whole-genome sequencing to trace, control and characterize the regional expansion of extended-spectrum -lactamase producing ST15 Klebsiella pneumoniae. Sci Rep 6:20840. https://doi.org/10.1038/srep20840.
64. ¨ a PH (ed), Pneumococcal vaccines: the impact of conjugate vaccine. ASM Press, Washington, DC.
65. Croucher NJ, Finkelstein JA, Pelton SI, Mitchell PK, Lee GM, Parkhill J, Bentley SD, Hanage WP, Lipsitch M. 2013. Population genomics of post-vaccine changes in pneumococcal epidemiology. Nat Genet 45: 656–663. https://doi.org/10.1038/ng.2625.